An open, randomized, multicentre phase II pilot study to evaluate the efficacy of budesonide 3 mg effervescent tablet in patients with resistant oral chronic GvHD using different application durations and treatment schedules
Latest Information Update: 20 Dec 2018
At a glance
- Drugs Budesonide (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- Sponsors Dr Falk Pharma
Most Recent Events
- 20 Dec 2018 New trial record